BPA Call 75H71224A00007-75H71224F28002

Award Date 7/15/24
Potential Completion Date 7/14/25
Potential Value $70K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parker, AZ, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a Blanket Purchase Agreement (BPA) Call valued at $69,870.49 to Biomerieux Inc., a global leader in in vitro diagnostics. The contract was awarded by the Indian Health Service, a civilian agency, for the provision of BioFire panel reagents. The contract has no set-aside designation and is being fulfilled under the In Vitro Diagnostics, Reagents, Test (FSS-65-VII) Federal Supply Schedule contract. Biomerieux Inc., through its Vitek Systems, Inc. division, has been...
The U.S. Department of Health and Human Services, Indian Health Service awarded a Blanket Purchase Agreement (BPA) call order to Biomerieux Inc. for BioFire panel reagents. The contract has a ceiling value of $1,216,476.00 and a period of performance through May 5, 2026. This BPA call order is under the larger Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits, which allows various federal agencies to procure Biomerieux's proprietary diagnostic products and...
This is a firm-fixed-price contract awarded by the Department of Health and Human Services Indian Health Service to Biomerieux Inc., a global leader in in vitro diagnostics and manufacturer of laboratory equipment, reagents, and supplies. The $11,874.51 contract is for the provision of lab supplies and reagents, with a period of performance through May 29, 2025. The award is issued as a Blanket Purchase Agreement (BPA) call and does not include any set-aside designations. Biomerieux Inc. holds...
This contract was awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to Biomerieux Inc. through its Biomerieux, Inc. division. The contract is for the delivery of laboratory supplies, specifically products from Biomerieux's portfolio of in vitro diagnostic equipment, reagents, and test kits. The contract has a firm-fixed-price structure and a ceiling value of $19,950.76 for the period of performance from February 1, 2020 to January...
This is a firm-fixed-price purchase order contract awarded to Biomerieux Inc. by the Indian Health Service, a civilian federal agency, for the provision of microbiology reagents, supplies, and support services. The contract has a ceiling value of $100,927.94 and a performance period ending on June 29, 2026. The contract was not set aside for any particular business category. Biomerieux Inc. is a global leader in in vitro diagnostics, specializing in the manufacture and distribution of advanced...
This is a firm-fixed-price delivery order contract awarded to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of laboratory reagent testing supplies. The contract was awarded by the Indian Health Service, a civilian agency, with a total ceiling value of $228,708.40 and a performance period ending on April 14, 2025. The contract is not set aside for any specific business category. Biomerieux Inc. will provide a range of products and services, including its...
This firm-fixed-price blanket purchase agreement (BPA) call was awarded by the Department of Health and Human Services' Indian Health Service to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $13,419.85, covers the supply of Biomerieux's proprietary microbiology testing equipment, reagents, and consumables for the period of July 1, 2024 to June 30, 2025. The award is placed under Biomerieux's existing Multiple Award Schedule (MAS) contract, which allows federal...
The federal contract award is for a Blanket Purchase Agreement (BPA) Call from the Indian Health Service, a civilian agency, to Biomerieux Inc. for the VIDAS 3 BPA. The contract has a ceiling value of $162,000.00 and a completion date of August 19, 2029. Biomerieux Inc., a for-profit organization and manufacturer of goods, is the prime contractor. The contract does not have a set-aside designation. This award is part of a larger Indefinite Delivery Vehicle (IDV) and Federal Supply Schedule...
The Department of Health and Human Services Indian Health Service awarded a firm-fixed-price purchase order contract to Biomerieux Inc., a foreign-owned for-profit organization and manufacturer of goods, for the provision of Biomerieux reagents and supplies on an as-needed basis. The contract has a potential value of $224,000.00 and a completion date of March 31, 2027. This contract is not set aside. Biomerieux Inc. is a worldwide leader in in vitro diagnostics, offering microbiological...
This is a firm-fixed-price delivery order contract awarded by the Indian Health Service (IHS), a civilian agency, to Biomerieux Inc. through its Biomerieux, Inc. division. The contract, valued at $10,401.82, is for the provision of laboratory supplies. The contract does not have a set-aside designation. Biomerieux Inc. is a global leader in in vitro diagnostics, providing a wide range of clinical diagnostic equipment, reagents, and supplies to various federal agencies, including the...

Biomerieux Inc., through its Biomerieux, Inc. Division, has been awarded a Blanket Purchase Agreement (BPA) call contract by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services. The $69,870.49 firm-fixed-price contract is for the provision of BioFire panel reagents under the Invitro Diagnostics, Reagents, Test Federal Supply Schedule contract. This contract does not have a set-aside designation. The contract has an ultimate completion date of July 14, 2025 and was awarded on July 15, 2024. Biomerieux Inc. is a global leader in in vitro diagnostics and has provided specialized diagnostic platforms, reagents, and technical services to support infectious disease testing and pathogen detection across various government healthcare operations.

Generated 2/8/25, 9:10 AM